Immunohistochemical expression of carbonic anhydrase IX in oral squamous cell carcinoma - A retrospective clinicopathological analysis in a tertiary care teaching hospital

口腔鳞状细胞癌中碳酸酐酶IX的免疫组织化学表达——一家三级教学医院的回顾性临床病理分析

阅读:2

Abstract

INTRODUCTION: Oral squamous cell carcinoma (OSCC) ranks as the sixth most prevalent cancer globally, with approximately one third of cases originating from India. Carbonic anhydrase IX (CA IX) is expressed essentially in tumor cells and is considered as a marker for tumor hypoxia. The present study aims to assess the association between immunohistochemical expression of CA IX in the tumor cells and the clinicopathological parameters of OSCC. MATERIALS AND METHODS: The present study is a 1 year retrospective study performed in a tertiary care teaching hospital. All radical specimens of OSCC were included in the study, and histopathological and immunohistochemical analysis for CA IX expression was performed manually in all cases. Statistical analysis was done using Statistical Package for the IBM Social Sciences (SPSS) software (version 26) (Armonk, New York, USA). The Chi squared test was used to calculate the value of significance (P). RESULTS: Of the 39 OSCCs included in the present study, 41.02% cases showed expression of CA IX. CA IX expression was seen to be significantly associated with presence of lymphovascular invasion, higher T and N stages, and higher depth of invasion. CONCLUSION: High CA IX expression in OSCC is a poor prognostic factor, and in view of availability of CAIX targeted therapeutic agents, it is essential to further study its use in treatment of such cases.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。